Aquestive Therapeutics, Inc.
AQST$3.83+0.79% 1D
$2.9552-week range$7.49
Updated . Prices are snapshots and may be delayed.
Aquestive Therapeutics, Inc. price chart
−18.68% over 7D
$4.74
$3.72
Oct 18
Oct 20
AI Outlook for Aquestive Therapeutics, Inc.
Bearish posture- Long-term trend-10.0% vs 200-day average
- Medium-term trend-18.7% vs 50-day average
- Averages50-day above 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Aquestive Therapeutics, Inc. performance
1D
+0.8%
7D
−20.4%
30D
−16.9%
90D
−5.2%
1Y
−44.0%
About Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc. is a pharmaceuticals company (ticker AQST).
Aquestive Therapeutics, Inc. market data
What is the price of Aquestive Therapeutics, Inc. today?
Aquestive Therapeutics, Inc. (AQST) is at $3.83, +0.79% on the day.
What is the 52-week range of Aquestive Therapeutics, Inc.?
Over the past year Aquestive Therapeutics, Inc. has traded between $2.95 and $7.49. It is currently 19% of the way up that range.
Similar stocks
LLY
Eli Lilly and Co
$1,240.34−0.2%
PFE
Pfizer Inc
$29.44+0.5%
HLN
Haleon PLC
$10.14+0.8%
EYPT
EyePoint, Inc. Common Stock
$0.44−20.0%
SXTC
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares
$0.1112+75.4%
SDEV
Stablecoin Development Corporat
$0.8384−8.2%
BMY
Bristol-Myers Squibb Company
$58.83−1.0%
VTRS
Viatris Inc.
$18.26−2.0%
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.